Catalyst Wire Dossier Catalyst Wire Dossier

Norovirus GI.1/GII.4 bivalent Virus-Like Particle (VLP) Vaccine

· Takeda
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Norovirus GI.1/GII.4 bivalent Virus-Like Particle (VLP) Vaccine, covering 2019-04-01 to 2019-04-01. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle (VLP) Vaccine in Children [Phase 2]

See pricing